Among patients with resected gallbladder cancer, the addition of chemoradiation to chemotherapy treatment did not improve ...

For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with fluorouracil, leucovorin, ox ...

For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) leads to improved survival compared with ...

Baseline characteristics were generally well balanced between the arms. In the perioperative chemotherapy arm, patients received fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT). In the ...

Sarcopenia and muscle loss predict poor outcomes in cervical cancer. Routine muscle assessment is vital for care.

With a median follow-up of 8.4 years, T-DM1 sustained the improvement in invasive disease–free survival over trastuzumab (unstratified hazard ratio for invasive disease or death, 0.54 ...

For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with ...

SBRT showed superiority over radiofrequency ablation in local progression-free survival and tumor control in small HCC but ...

The PEACE-1 trial (NCT01957436) revealed that adding radiotherapy to standard of care (SOC) and abiraterone significantly ...

Adding camrelizumab and rivoceranib to TACE improved PFS in patients with unresectable HCC in a phase 2 trial.